Paolo Marchetti

Pubblicazioni

Titolo Pubblicato in Anno
Current challenges in HER2-positive breast cancer CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2016
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. a “real life” retrospective analysis of progression-free (PFS) and overall survival (OS) according to duration of androgen deprivation therapy JOURNAL OF CLINICAL ONCOLOGY 2016
Commentary on "a case of paratesticular leiomyosarcoma successfully treated with orchiectomy and chemotherapy" CANCER RESEARCH AND TREATMENT 2016
Pre-treatment evaluation of 5-fluorouracil degradation rate. association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort ONCOTARGET 2016
CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy THE EURASIAN JOURNAL OF MEDICINE 2016
Evolving treatments for advanced gastric cancer: appraisal of the survival trend EXPERT REVIEW OF ANTICANCER THERAPY 2016
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies EXPERT REVIEW OF VACCINES 2016
H2020 and beyond: skip discrepancy between theory and practice of personalized medicine. A position paper by the italian society of personalized medicine CURRENT PHARMACEUTICAL BIOTECHNOLOGY 2016
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer ANTI-CANCER DRUGS 2016
High prevalence of ALK+/ROS1+ cases in pulmonary adenocarcinoma of adoloscents and young adults LUNG CANCER 2016
Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer ONCOTARGET 2016
Degradation rate of 5-fluorouracil in metastatic colorectal cancer. A new predictive outcome biomarker? PLOS ONE 2016
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX ANTI-CANCER DRUGS 2016
Neoadjuvant sequential docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab. The DECT trial JOURNAL OF CELLULAR PHYSIOLOGY 2016
Metabolic determinants and anthropometric indicators impact clinical-pathological features in epithelial ovarian cancer patients JOURNAL OF CANCER 2016
Exploring the Prognostic Role of Microsatellite Instability in Patients With Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis CLINICAL COLORECTAL CANCER 2016
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients. A multicenter Italian experience THE BREAST 2016
A rare case of palatin tonsillar metastasis from small cell lung cancer TRANSLATIONAL LUNG CANCER RESEARCH 2016
High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art DIGESTIVE AND LIVER DISEASE 2016
Re. "Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey" NUTRITION 2016

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma